Virtual Medicinal Product (VMP) - Risankizumab 360mg/2.4ml solution for injection cartridges
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Risankizumab 360mg/2.4ml solution for injection cartridges | Start Date 13-09-2023 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 2.4
- UDFS UOM
- ml
- Unit Dose UOM
- cartridge
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L04AC18
- BNF Codes
-
- BNF code 01050300
| Code | Start Date | End Date |
|---|---|---|
| 42251811000001100 | 13-09-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Risankizumab | Based on Ingredient Substance | 150 mg | 1 ml |
Name
Risankizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMRisankizumab
-
VMP(Current) Risankizumab 360mg/2.4ml solution fo...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 cartridge |